Preop RT May Boost Response to Chemo-Immunotherapy in High-Risk Early Breast Cancer

(MedPage Today) — SAN ANTONIO — Preoperative radiotherapy (RT) plus PD-1 inhibitor pembrolizumab (Keytruda) significantly increased immune activation and tumor response in node-positive hormone receptor-positive (HR+)/HER2-negative breast cancer…

Read the full article on medpagetoday.com